Abcellera Biologics Inc
NASDAQ:ABCL
Abcellera Biologics Inc
Pre-Tax Income
Abcellera Biologics Inc
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Pre-Tax Income
-$174m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Pre-Tax Income
-CA$5.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-39%
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Pre-Tax Income
-CA$69.3k
|
CAGR 3-Years
69%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
Innovotech Inc
XTSX:IOT
|
Pre-Tax Income
-CA$176.8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
12%
|
See Also
What is Abcellera Biologics Inc's Pre-Tax Income?
Pre-Tax Income
-174m
USD
Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Pre-Tax Income amounts to -174m USD.